Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001362310-08-000906
Filing Date
2008-02-14
Accepted
2008-02-14 12:17:52
Documents
1
Group Members
JOHN S. CLARK IIROBERT W. BUTTSSOUTHPOINT CAPITAL ADVISORS LLCSOUTHPOINT GP, LLCSOUTHPOINT GP, LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A c72464sc13gza.htm SC 13G/A 89996
  Complete submission text file 0001362310-08-000906.txt   92131
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Subject) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50514 | Film No.: 08611160
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017
Business Address 237 PARK AVENUE SUITE 900 NEW YORK NY 10017 212.692.6350
Southpoint Capital Advisors LP (Filed by) CIK: 0001319998 (see all company filings)

EIN.: 200975910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A